Safety comes second

Safety comes second

Author: The BMJ August 28, 2013 Duration: 17:00

Last week saw Safety 2010, the international conference on preventable accidents. We hear from some of the speakers there why safety comes second when it comes to global health.

Also this week, female sexual dysfunction - fact or fiction. In advance of a BMJ debate on the topic, we get to the heart of the issue.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Is advice to cut down smoking wrong? [not-audio_url] [/not-audio_url]

Duration: 16:49
New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit. In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medi…
Investigating UTIs in older adults [not-audio_url] [/not-audio_url]

Duration: 11:05
UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins…
Alcohol - The UK’s billion unit pledge is worthless [not-audio_url] [/not-audio_url]

Duration: 19:45
The BMJ has been investigating the “cosy relationship” between the alcohol industry and the British government. In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government…
Patient confidentiality in the digital age [not-audio_url] [/not-audio_url]

Duration: 17:59
Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School, outline the regulations governing confidenti…
The problems with testosterone testing in female athletes [not-audio_url] [/not-audio_url]

Duration: 17:56
The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism.…
Should doctors be prescribing cannabinoids? [not-audio_url] [/not-audio_url]

Duration: 18:54
Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids.…
Using HbA1c to diagnose type 2 diabetes [not-audio_url] [/not-audio_url]

Duration: 14:56
Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high…
How to manage the first seizure in an adult [not-audio_url] [/not-audio_url]

Duration: 29:43
First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key. Heather Angus-Leppan, consultant neurologist and epil…
Tamiflu US Press Conference [not-audio_url] [/not-audio_url]

Duration: 32:35
Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has sho…